Infectociprocort

Ciprofloxacin and Fluocinolone Acetonide, the active ingredients in Infectociprocort, are a fluoroquinolone and a corticosteroid presented as an auricular preparation for ear use. The combination provides antibacterial activity together with local anti‑inflammatory effect for ear conditions. GNH USA supplies Infectociprocort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infectociprocort is indicated for ear conditions where bacterial infection and inflammation coexist.

Otitis externa: reduces bacterial load and alleviates inflammation in the external auditory canal. Bacterial ear infection with inflammatory component: treats the infection while controlling local swelling and pain. Post‑traumatic ear canal inflammation: helps prevent secondary infection and eases inflammatory symptoms.

Infectociprocort may cause local and systemic adverse reactions.

Common Side Effects: - Ear discomfort or burning sensation. - Pruritus or mild irritation of the ear canal. - Transient redness or swelling at the application site. - Temporary hearing changes that resolve after treatment. - Mild headache. - Nausea (rare with systemic absorption).

Serious or Rare Side Effects: - Allergic reaction: rash, urticaria, or angioedema. - Ototoxicity: persistent hearing loss or vestibular dysfunction. - Severe local inflammation or ulceration. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic fluoroquinolone effects: tendon rupture, QT prolongation. - Corticosteroid‑related adrenal suppression with prolonged use.

Use Infectociprocort only under medical supervision and consider the following precautions.

Pregnancy: consult a healthcare professional before use; safety data are limited. Breastfeeding: evaluate risk versus benefit, as small amounts may be excreted in milk. Allergy: avoid if known hypersensitivity to ciprofloxacin, fluoroquinolones, or corticosteroids. Perforated tympanic membrane: use only if advised, as systemic absorption may increase. Concurrent ototoxic drugs: monitor hearing function when used with aminoglycosides or loop diuretics. Store at room temperature: keep in the original container, protect from moisture and direct light.

Infectociprocort can interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid): - Systemic fluoroquinolones: additive toxicity and increased risk of tendon disorders. - Ototoxic agents (e.g., aminoglycosides, loop diuretics): heightened risk of hearing loss. - Live vaccines: systemic immunosuppression may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: may reduce ciprofloxacin absorption; separate dosing by at least 2 hours. - CYP450 inhibitors (e.g., ketoconazole): can increase fluocinolone levels. - NSAIDs: may increase risk of gastrointestinal irritation. - Warfarin: monitor INR as fluoroquinolones can potentiate anticoagulant effect.